Further investigations utilizing human PPARα transgenic mice are needed to better exploit the utility of animal studies in exploring the role of PPARα in human-relevant metabolic syndrome and NAFLD models. This evidence concerns the gene PPARA and metabolic dysfunction-associated steatotic liver disease.